The ongoing arguments and resultant uncertainty preceding the will they/won’t they repeal the medical device sales tax in USA is helping nobody, so thank goodness there are signs that it might just be “repealed under the carpet” soon.
In the meantime, media commentators remain glued to their keyboards, opining on the subject and in most cases finding more and more angles from which to issue assaults on what seems to be commonly held up as a piece of ill-considered legislation.
One especially interesting piece has caught our eye today in the form of an article in Forbes magazine. The author, one John Graham, builds his commentary around two fundamental tenets: Firstly the assertion that not only does the tax harm companies and employment, but secondly that by crushing investment in innovation it deprives people of new technology which could save their lives… ergo it kills them. I think we’ll brush over the rather overt headline grab-although it did its job I suppose-because the idea that investment saves lives is one without a sensible end. Surely we should be investing more, more, more, on the basis that if less investment costs lives then more should save them. It’s plain daft.
What’s far more salient and fair comment is John Graham’s analysis that the medical device industry has been super-effective in driving the argument and with it the repeal proceedings, punching the point home to an extent well above the queue of issues on the table as parts of Obamacare.
Read the article here, because it’s good… apart from the headline.